A detailed history of Peapack Gladstone Financial Corp transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Peapack Gladstone Financial Corp holds 15,443 shares of TEVA stock, worth $264,229. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,443
Previous 26,163 40.97%
Holding current value
$264,229
Previous $369,000 31.98%
% of portfolio
0.0%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$12.78 - $17.4 $137,001 - $186,527
-10,720 Reduced 40.97%
15,443 $251,000
Q1 2024

May 10, 2024

SELL
$10.67 - $14.43 $136,864 - $185,093
-12,827 Reduced 32.9%
26,163 $369,000
Q4 2023

Feb 13, 2024

SELL
$8.12 - $10.63 $142,246 - $186,216
-17,518 Reduced 31.0%
38,990 $407,000
Q3 2023

Nov 14, 2023

SELL
$7.48 - $10.7 $88,196 - $126,163
-11,791 Reduced 17.26%
56,508 $576,000
Q2 2023

Aug 14, 2023

SELL
$7.2 - $9.47 $38,959 - $51,242
-5,411 Reduced 7.34%
68,299 $514,000
Q1 2023

May 15, 2023

SELL
$8.36 - $11.37 $45,077 - $61,307
-5,392 Reduced 6.82%
73,710 $652,000
Q4 2022

Feb 14, 2023

SELL
$7.95 - $9.48 $17,895 - $21,339
-2,251 Reduced 2.77%
79,102 $721,000
Q3 2022

Nov 10, 2022

BUY
$6.86 - $11.95 $27,927 - $48,648
4,071 Added 5.27%
81,353 $657,000
Q2 2022

Aug 12, 2022

BUY
$7.38 - $10.4 $22,922 - $32,302
3,106 Added 4.19%
77,282 $581,000
Q1 2022

May 16, 2022

BUY
$7.33 - $9.39 $122,301 - $156,672
16,685 Added 29.02%
74,176 $697,000
Q4 2021

Feb 15, 2022

BUY
$7.9 - $10.19 $58,689 - $75,701
7,429 Added 14.84%
57,491 $461,000
Q3 2021

Nov 15, 2021

BUY
$8.38 - $10.18 $42,101 - $51,144
5,024 Added 11.16%
50,062 $488,000
Q2 2021

Aug 16, 2021

SELL
$9.9 - $11.56 $6,207 - $7,248
-627 Reduced 1.37%
45,038 $446,000
Q1 2021

May 14, 2021

BUY
$10.34 - $12.81 $472,176 - $584,968
45,665 New
45,665 $527,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Peapack Gladstone Financial Corp Portfolio

Follow Peapack Gladstone Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peapack Gladstone Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Peapack Gladstone Financial Corp with notifications on news.